Skip to main content
eScholarship
Open Access Publications from the University of California

Fixed drug eruption related to sunitinib: a case report

  • Author(s): Bhatia, Anuradha
  • Jha, Niharika
  • Kanish, Bimal
  • et al.
Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International Public License
Abstract

Sunitinib is an oral multi-targeted tyrosine kinase inhibitor. It has been approved for the treatment of gastro-intestinal stromal tumor and advanced renal cell carcinoma. Fixed drug eruption related to sunitinib is a rare cutaneous adverse drug reaction.

Main Content
Current View